Bristol Myers Squibb (BMY) Shareholder Lodestar Investment Counsel Cut Stake, As Cummins (CMI) Market Value … – BZ Weekly


Bristol Myers Squibb (BMY) Shareholder Lodestar Investment Counsel Cut Stake, As Cummins (CMI) Market Value ...
BZ Weekly
Lodestar Investment Counsel Llc decreased its stake in Bristol Myers Squibb (BMY) by 15.78% based on its latest 2016Q4 regulatory filing with the SEC. Lodestar Investment Counsel Llc sold 23,538 shares as the company's stock declined 1.04% while stock ...

and more »

Bristol Myers Squibb (BMY) Shareholder Lodestar Investment Counsel Cut Stake, As Cummins (CMI) Market Value … – BZ Weekly Kitimi Business.

Bristol-Myers Squibb Company’s (BMY) is at $53.78 per share and The Medicines Company’s (MDCO) is listed at … – Stocks Gallery


Bristol-Myers Squibb Company's (BMY) is at $53.78 per share and The Medicines Company's (MDCO) is listed at ...
Stocks Gallery
In recent trading day Bristol-Myers Squibb Company (BMY) stock showed the move of -1.16% with the closing price of $53.78. Closing price generally refers to the last price at which a stock trades during a regular trading session. The company moved in ...

and more »

Bristol-Myers Squibb Company’s (BMY) is at $53.78 per share and The Medicines Company’s (MDCO) is listed at … – Stocks Gallery Kitimi Business.

Analysts mean rating score stands at 2.40 while Bristol-Myers Squibb Company’s (BMY) stock price is Worth at $56.29 … – Hot Stocks Point


Analysts mean rating score stands at 2.40 while Bristol-Myers Squibb Company's (BMY) stock price is Worth at $56.29 ...
Hot Stocks Point
Bristol-Myers Squibb Company (BMY) stock price ended its day with loss -1.78% and finalized at the price of $56.29. During its last trading session, Stock traded with the total exchanged volume of 15.88 million shares. The average volume stands around ...

and more »

Analysts mean rating score stands at 2.40 while Bristol-Myers Squibb Company’s (BMY) stock price is Worth at $56.29 … – Hot Stocks Point Kitimi Business.

Leerink Swann Research Analysts Lower Earnings Estimates for Bristol-Myers Squibb Co. (BMY) – The Cerbat Gem


The Cerbat Gem

Leerink Swann Research Analysts Lower Earnings Estimates for Bristol-Myers Squibb Co. (BMY)
The Cerbat Gem
Bristol-Myers Squibb logo Bristol-Myers Squibb Co. (NYSE:BMY) – Equities researchers at Leerink Swann cut their Q4 2016 earnings per share estimates for shares of Bristol-Myers Squibb in a report issued on Thursday. Leerink Swann analyst S. Fernandez ...

and more »

Leerink Swann Research Analysts Lower Earnings Estimates for Bristol-Myers Squibb Co. (BMY) – The Cerbat Gem Kitimi Business.